Baxalta Innovations GmbH
Records under this name other than patents Baxalta Innovations GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Baxalta Innovations GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,370,694 | Grip Detection System for Liquid Handling Robot Formerly held In force · High confidence | In force | High confidence | |
| US 8,703,426 | Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV Term ended Ended no later than Feb 7, 2023 · Low confidence | Term ended | Ended no later than Feb 7, 2023 | Low confidence |
| US 8,703,429 | Composition Exhibiting a Von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence Aaggilhlellv Term ended Ended no later than Oct 11, 2022 · Low confidence | Term ended | Ended no later than Oct 11, 2022 | Low confidence |
| US 7,033,590 | Factor IX/factor IXa activating antibodies and antibody derivatives Formerly held Term ended Term ended Dec 20, 2021 · USPTO record | Term ended | Term ended Dec 20, 2021 | USPTO record |
| US 6,958,322 | Factor X analog with an improved ability to be activated Formerly held Term ended Term ended Sep 3, 2021 · USPTO record | Term ended | Term ended Sep 3, 2021 | USPTO record |
| US 6,974,792 | Alpha 1-Antitrypsin Preparation as Well as a Method for Producing the Same Term ended Term ended Jun 10, 2021 · Medium confidence | Term ended | Term ended Jun 10, 2021 | Medium confidence |
| US 6,926,894 | Composition Exhibiting a Von Willebrand Factor (VWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence Aaggilhlellv Term ended Term ended May 13, 2021 · Medium confidence | Term ended | Term ended May 13, 2021 | Medium confidence |
| US 8,709,492 | Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals Term ended Term ended May 4, 2021 · Medium confidence | Term ended | Term ended May 4, 2021 | Medium confidence |
| US 8,722,406 | Medium for the Protein-Free and Serum-Free Cultivation of Cells Formerly held Term ended Term ended Feb 3, 2021 · Medium confidence | Term ended | Term ended Feb 3, 2021 | Medium confidence |
| US 7,241,603 | Method for Producing a Preparation Based on Fibrinogen and Fibronectin as Well as Protein Compositions Obtainable According to This Method Term ended Term ended Dec 1, 2020 · Medium confidence | Term ended | Term ended Dec 1, 2020 | Medium confidence |